Pluri News and Resources

Pluri Inc., has announced a new collaboration with Bar-Ilan University’s research and development arm, BIRAD. Funded by the Israel Innovation Authority (IIA), the project will support the development of Placental Mucosal Associated Invariant T (MAIT) cells as a novel treatment